Anesthetics Market : Facts, Figures and Analytical Insights 2020

The Anesthetics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of COVID-19 (Corona Virus) on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.

The global anesthetics market was valued at about $9.32 billion in 2018 and is expected to decline to $9.13 billion at a CAGR of -0.5% through 2022.

The anesthetics market consists of sales of drugs that cause a relaxing sensation to calm patients during surgery and remove the sensation of pain. These drugs are used to give a sense of calm to patients through muscle relaxation which also causes amnesia. The anesthetics market is divided into general anesthetics, regional anesthetics and local anesthetics.

Click the link to get a Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/05072013677/anesthetics-global-market-report-2020-including-1-by-type-general-anesthetics-local-anesthetics-2-by-application-general-surgeries-plastic-surgery-cosmetic-surgeries-dental-surgeries-other-applications-3-by-route-of-administration-inhalation-anaesthesia-drugs-intravenous-anaesthesia-drugs-topical-anaesthesia-drugs-4-by-local-anesthetics-bupivacaine-ropivacaine-lidocaine-chloroprocaine-articaine-benzocaine-other-local-anesthesia-drugs-5-by-general-anesthetics-propofol-sevoflurane-desflurane-dexmedetomidine-remifentanil-midazolam-other-general-anesthesia-drugs-covering-baxter-abbott-laboratories-astrazeneca-f-hoffmann-la-roche-ag-b-braun-melsungen-ag/inquiry?source=openpr&Mode=12

Major players in the market are Baxter, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, B. Braun Melsungen AG

Mar 06, 2019: Baxter Announces U.S. FDA Approval and Launch of Ready-to-Use Cardiovascular Medicine Eptifibatide

DEERFIELD, Ill.-- Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide. Baxter’s presentation of eptifibatide is the first of its kind available in a flexible container.

“Hospital pharmacists are unsung heroes working behind the scenes to make sure every dose of medication is delivered accurately and on-time to patients,” said Robert Felicelli, president, Pharmaceuticals, Baxter. “By adding more essential premix medicines—like eptifibatide—to Baxter’s broad portfolio, we can help support pharmacy efficiency, reduce waste and enhance patient safety.”

Eptifibatide is a platelet aggregation inhibitor that prevents platelets—specialized blood cells—from sticking together and clotting. Eptifibatide is indicated for medical treatment of acute coronary syndrome (ACS), a broad term that includes heart attack and other emergency conditions in which the blood supply to the heart is suddenly stopped. Eptifibatide is also indicated for treatment of patients undergoing percutaneous coronary intervention (PCI), in which physicians insert a catheter to visualize and open blocked coronary arteries and may, if needed, implant a mesh tube, called a stent, to keep the artery open.

September 14, 2017: AstraZeneca Sells Remaining Anesthetics Portfolio to Aspen in $766M Deal
Under the terms of the new agreement, AGI will now acquire the remaining rights to the intellectual property and manufacturing know-how related to the anesthetic medicines for an upfront consideration of $555 million. Additionally, AGI will pay AstraZeneca up to $211 million in performance-related milestones based on sales and gross margin during the period from 1 September 2017 to 30 November 2019.

“AstraZeneca, AGI, and patients have all benefitted from the successful commercial agreement we established last year,” said Mark Mallon, Executive Vice President, Global Product and Portfolio Strategy, AstraZeneca. “As our relationship has evolved, AGI has shown that it is in a strong position to maximize the value and reach of the anesthetic medicines through its extensive commercial network. Disposing the remaining rights to the medicines allows both companies to benefit from greater efficiencies as AstraZeneca continues to focus our resources on our three main therapy areas.”

MARKET OVERVIEW:

North America was the largest region in the anesthetics market in 2017, followed by Europe. This region is expected to remain the largest during the next five years. The anesthetics market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

The increase in the number of surgeries is one of the major drivers of the anesthetics market due to the applications of anesthetic drugs during surgical procedures. This rise is mainly due to increasing incidents of injuries and accidents that require surgeries. For example, according to WHO's Global status report on road safety 2018, the number of road accidents reached 1.35 million in 2016, with approximately 64 deaths for every 100,000 vehicles.

Stringent guidelines and regulations imposed by regulatory bodies are one of the important restraints for the anesthetics market. These guidelines include conducting clinical trials of newly developed drugs, standards related to patient’s safety, and monitoring of patients under anesthesia. Complying with these guidelines and getting regulatory approvals consumes a lot of time and negatively impacts the growth of the anesthetics market. For example, the American Society of Anesthesiologists impose various standards that apply to anesthesia care and monitoring of patient including standards for pre-, basic- and post-anesthesia care and monitoring.

Increasing consolidation in the form of acquisitions is an emerging trend in the anesthetics market. This is mainly due to high level of R&D and intellectual property (IP) investment needed to establish companies that manufacture anesthetic drugs. In this regard, mergers and acquisitions are considered as time and cost-effective methods. Some of the notable acquisitions in the recent years include acquisition of MyoScience by Pacira for $220 million in 2019, acquisition of Claris Injectables by Baxter for $625 million in 2017, acquisition of GSK's anesthetics portfolio by Aspen for $238.7 million in 2017, and acquisition of Hospira by Pfizer for $17 billion in 2015.

In 1977, the US food and drug administration released a document outlining the guidelines to be followed when conducting clinical trials for general anesthetic drugs. This document gives instructional information on how to select clinical subjects, proper drug administration procedures and important metrics to be noted down. Examples of important metrics include signs of relaxation, salivation and feelings of irritation after administering the anesthetic. This document was revised in 1982 and is still in use today. Regulations such as these are expected to keep a check on the general anesthetic drugs market.

INFLUENCE OF THE Anesthetics MARKET REPORT:

-Comprehensive assessment of all opportunities and risk in the Anesthetics market.
- Anesthetics market recent innovations and major events.
-A detailed study of business strategies for growth of the Anesthetics market-leading players.
-Conclusive study about the growth plot of Anesthetics market for forthcoming years.
-In-depth understanding of Anesthetics market-particular drivers, constraints and major micro markets.
-Favourable impression inside vital technological and market latest trends striking the Anesthetics market.

WHAT ARE THE MARKET FACTORS THAT ARE EXPLAINED IN THE REPORT?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on regional scale.

Analytical Tools: The Anesthetics Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

The report has 150 tables and figures browse the report description and TOC:
https://www.marketinsightsreports.com/reports/05072013677/anesthetics-global-market-report-2020-including-1-by-type-general-anesthetics-local-anesthetics-2-by-application-general-surgeries-plastic-surgery-cosmetic-surgeries-dental-surgeries-other-applications-3-by-route-of-administration-inhalation-anaesthesia-drugs-intravenous-anaesthesia-drugs-topical-anaesthesia-drugs-4-by-local-anesthetics-bupivacaine-ropivacaine-lidocaine-chloroprocaine-articaine-benzocaine-other-local-anesthesia-drugs-5-by-general-anesthetics-propofol-sevoflurane-desflurane-dexmedetomidine-remifentanil-midazolam-other-general-anesthesia-drugs-covering-baxter-abbott-laboratories-astrazeneca-f-hoffmann-la-roche-ag-b-braun-melsungen-ag?source=openpr&Mode=12

CUSTOMIZATION OF THE REPORT:

MarketInsightsReports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
If you have any questions about any of our “Anesthetics market report” or would like to schedule a personalized free demo of Anesthetics market report, please do not hesitate to contact me at irfan@marketinsightsreports.com.

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides Global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Best wishes,
Irfan Tamboli
Head of Sales Operations
Market Insights Reports
Tel: + 1704 266 3234 | +91-750-707-8687
Email: sales@marketinsightsreports.com | irfan@marketinsightsreports.com

This release was published on openPR.